| |
| |
|
| Insider
Information: |
Foley Todd |
| Relationship: |
Director, 10% Owner |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
9 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
24,224,604 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$92,884,028 |
|
|
| Total
Shares |
24,224,604 |
|
|
| Total
Value |
$92,884,028 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -66.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Celladon Corp |
CLDN |
Director |
2014-02-04 |
0 |
2014-02-04 |
1,066,775 |
Premium* |
|
|
Aratana Therapeutics, Inc. |
PETX |
10% Owner |
2014-03-07 |
0 |
2014-03-07 |
3,351,048 |
Premium* |
|
|
Chiasma, Inc |
CHMA |
Director, 10% Owner |
2015-07-21 |
0 |
2015-07-21 |
5,681,544 |
Premium* |
|
|
Avalo Therapeutics, Inc |
AVTX |
10% Owner |
2015-10-20 |
0 |
2015-10-20 |
595,436 |
Premium* |
|
|
Radius Health Inc. |
RDUS |
Former 10% stockholder |
2016-09-27 |
0 |
2016-09-27 |
1,427,698 |
Premium* |
|
|
Rhythm Pharmaceuticals, Inc. |
RYTM |
Director |
2017-10-10 |
0 |
2021-03-15 |
909,258 |
Premium* |
|
|
Harpoon Therapeutics, Inc. |
HARP |
10% Owner |
2019-02-12 |
0 |
2019-02-12 |
4,524,425 |
Premium* |
|
|
Repare Therapeutics Inc. |
RPTX |
Director |
2020-06-23 |
0 |
2021-07-12 |
2,242,636 |
Premium* |
|
|
Entrada Therapeutics, Inc. |
TRDA |
Director, 10% Owner |
2021-11-02 |
0 |
2021-11-02 |
4,425,784 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
86 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RPTX |
Repare Therapeutics Inc. |
Director |
– • – |
2021-06-21 |
4 |
AS |
$33.80 |
$571,421 |
I/I |
(16,562) |
2,293,384 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
Director |
– • – |
2021-06-22 |
4 |
AS |
$33.36 |
$56,016 |
I/I |
(1,675) |
2,291,709 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
Director |
– • – |
2021-06-23 |
4 |
AS |
$32.98 |
$20,514 |
I/I |
(622) |
2,291,087 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
Director |
– • – |
2021-06-24 |
4 |
AS |
$33.53 |
$90,430 |
I/I |
(2,697) |
2,288,390 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
Director |
– • – |
2021-06-25 |
4 |
AS |
$33.51 |
$333,190 |
I/I |
(9,943) |
2,278,447 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
Director |
– • – |
2021-06-28 |
4 |
AS |
$34.06 |
$248,521 |
I/I |
(7,270) |
2,271,177 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
Director |
– • – |
2021-06-29 |
4 |
AS |
$33.29 |
$39,615 |
I/I |
(1,190) |
2,269,987 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
Director |
– • – |
2021-07-09 |
4 |
AS |
$33.06 |
$59,244 |
I/I |
(1,792) |
2,268,195 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
Director |
– • – |
2021-07-12 |
4 |
AS |
$33.58 |
$858,434 |
I/I |
(25,559) |
2,242,636 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Director |
– • • |
2021-11-02 |
4 |
A |
$0.00 |
$0 |
I/I |
4,325,784 |
4,325,784 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Director |
– • • |
2021-11-02 |
4 |
B |
$20.00 |
$2,000,000 |
I/I |
100,000 |
4,425,784 |
2.25 |
- |
|
86 Records found
|
|
Page 4 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
